FindTrial
Sign In

Comparison between three brands of nasal spray for the treatment of allergic rhinitis

Comparison of three topical budesonide brands in the treatment of allergic rhinitis: randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4yccqm
Enrollment
Unknown
Registered
2020-07-22
Start date
2018-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis

Interventions

Ninety patients diagnosed with allergic rhinitis will be analyzed, based on clinical data (sneezing, runny nose, nasal and / or eye itching) and confirmed by a specific IgE (serological) test. The pop
Drug
C08.460.799.315

Sponsors

Clinica Olfact
Lead Sponsor
Clinica Olfact
Collaborator

Eligibility

Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Patients aged between 18 and 55 years who were diagnosed with allergic rhinitis through clinical criteria and positive specific IgE

Exclusion criteria

Exclusion criteria: Patients under the age of 18 and over 55, with rhinitis triggered by other reasons, other than allergic.

Design outcomes

Primary

MeasureTime frame
Five percent increase in the score obtained in tests performed after treatment, compared to the score obtained at the beginning of the study—

Secondary

MeasureTime frame
Evaluate the possible side effects of using the study drugs due to the worsening of test results applied at the end of the study, compared to the initial result—

Countries

Brazil

Contacts

Public ContactMarco Fornazieri

Clinica Olfact

marcofornazieri@gmail.com+554330291436

Outcome results

None listed

Source: REBEC (via WHO ICTRP)